Demetrix Raises $50 Million to Pursue Cannabinoid Biosynthesis

  Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies Funding Round led by Tuatara Capital with Continued Participation by Horizons Ventures EMERYVILLE, Calif., July 11, 2019 /PRNewswire/ — Today, Demetrix Inc., a biotechnology company focused on the production of cannabinoids, announced that it has secured […]

Go to OG News Source
Author: NCV Newswire
{authorlink}